Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
EV/Core EBITDA

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

DR LAL PATHLABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 25.1926.7427.8634.9944.38

What is the latest EV/Core EBITDA ratio of DR LAL PATHLABS ?

The latest EV/Core EBITDA ratio of DR LAL PATHLABS is 25.19 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202525.19
Mar202426.74
Mar202327.86
Mar202234.99
Mar202144.38

How is EV/Core EBITDA of DR LAL PATHLABS Trending?

Years EV/Core EBITDA % Change
Mar2025 25.19
-5.80
Mar2024 26.74
-4.02
Mar2023 27.86
-20.38
Mar2022 34.99
-21.16
Mar2021 44.38 -

Other Financial Ratios of DR LAL PATHLABS


Compare EV/Core EBITDA ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹22,219.6 Cr -2.2% -7.6% 6.6% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹104,421.0 Cr -3.8% -4.4% 22.4% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹92,749.5 Cr -3.7% -11.4% -1.1% Stock Analytics
FORTIS HEALTHCARE ₹61,868.8 Cr -2.4% -9.6% 39.8% Stock Analytics
NARAYANA HRUDAYALAYA ₹33,664.4 Cr -1.3% -9.9% 9.7% Stock Analytics
GLOBAL HEALTH ₹27,260.7 Cr -5.4% -13.6% -11.2% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

-2.2%

-7.6%

6.6%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses